Cancer Research and Treatment

Original Articles

General

Adherence to Cancer Prevention Guidelines and Cancer Incidence and Mortality: A Population-Based Cohort Study: Jin-Kyoung Oh, Minji Han, Byungmi Kim, Eun Young Park; Cancer Res Treat. 2023;55(1):15-27. Published online March 22, 2022; DOI: https://doi.org/10.4143/crt.2021.1031

Abstract PDF Supplementary Material PubReader ePub

Purpose
This study aimed to estimate the risk of cancer incidence and mortality according to adherence to lifestyle-related cancer prevention guidelines.
Materials and Methods
Men and women who participated in the general health screening program in 2002 and 2003 provided by the National Health Insurance Service were included (n=8,325,492). Self-reported smoking, alcohol consumption, and physical activity habits and directly measured body mass index were collected. The participants were followed up until the date of cancer onset or death or 31 December 2018. The Cox proportional hazard model was used to evaluate the hazard ratio (HR) for cancer incidence and mortality according to different combinations of lifestyle behaviors.
Results
Only 6% of men and 15% of women engaged in healthy behavior at baseline, such as not smoking, not drinking alcohol, being moderately or highly physically active, and within a normal body mass index range. Compared to the best combination of healthy lifestyle behaviors, the weak and moderate associations with increased all cancer incidence (HR < 1.7) and mortality (HR < 2.5) were observed in those with heavy alcohol consumption and in former or current smokers. HRs of cancer mortality were significantly increased among current smokers in most combinations.
Conclusion
Compared to full adherence to cancer prevention recommendations, unhealthy behaviors increase cancer risk. As few people meet these recommendations, there is a great opportunity for cancer prevention.

Citations

Citations to this article as recorded by

Increased risk of cardiovascular disease among kidney cancer survivors: a nationwide population-based cohort study
Minji Jung, Eunjung Choo, Shufeng Li, Zhengyi Deng, Jinhui Li, Mingyi Li, Satvir Basran, Sukhyang Lee, Marvin E. Langston, Benjamin I. Chung
Frontiers in Oncology.2024;[Epub] CrossRef
Cancer survivors’ adherence to the American cancer society and American institute of cancer research dietary guidelines in Lebanon
Jana Jabbour, Remie El Helou, Ruba Hadla, Riwa Azar, Maria Mezher, Farah Naja, Sally Temraz
BMC Public Health.2024;[Epub] CrossRef
Longitudinal Trends of Comorbidities and Survival Among Kidney Cancer Patients in Asian Population
Minji Jung, Eunjung Choo, Jinhui Li, Zhengyi Deng, Marvin E. Langston, Sukhyang Lee, Benjamin I. Chung
Cancer Medicine.2024;[Epub] CrossRef
Combinations of lifestyle behaviors and cancer risk among Korean adults
Ngoc Minh Luu, Thi Tra Bui, Thi Phuong Thao Tran, Thi Huyen Trang Nguyen, Jin-Kyoung Oh
Scientific Reports.2023;[Epub] CrossRef
Individual and joint effect of socioeconomic status and lifestyle factors on cancer in Korea
Chi Lan Tran, Kui Son Choi, Sun‐Young Kim, Jin‐Kyoung Oh
Cancer Medicine.2023; 12(16): 17389. CrossRef
Tumorkachexie: die Bedeutung von Ernährung und Bewegung in der Onkologie
Yurdagül Zopf, Hans Joachim Herrmann, Dejan Reljic, Luisa Marie Hardt
Zeitschrift für Komplementärmedizin.2023; 15(06): 12. CrossRef
Adherence to the World Cancer Research Fund/American Institute for Cancer Research and Korean Cancer Prevention Guidelines and cancer risk: a prospective cohort study from the Health Examinees-Gem study
Jeeyoo Lee, Aesun Shin, Woo-Kyoung Shin, Ji-Yeob Choi, Daehee Kang, Jong-Koo Lee
Epidemiology and Health.2023; 45: e2023070. CrossRef

6,229 View
278 Download
4 Web of Science
7 Crossref

Skin cancer

Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data: TaeHo Kim, Siyeong Yoon, Dong-Eun Shin, Sang Cheol Lee, Jisu Oh, So-Young Lee, Do Kyung Kim, Segi Kim, Bosung Jung, Minsup Kim, Soonchul Lee; Cancer Res Treat. 2022;54(3):937-949. Published online September 30, 2021; DOI: https://doi.org/10.4143/crt.2021.871

Abstract PDF Supplementary Material PubReader ePub

Purpose
Melanoma incidence is rising worldwide along with the associated personal and socioeconomic health expenditures. We investigated the incidence and survival-rate patterns of melanoma in South Korea using nationwide data.
Materials and Methods
This retrospective cohort study included patients with melanoma between 2004 and 2017, based on National Health Insurance (NHI) claims data in South Korea. The incidence, prevalence, and survival rate were analyzed along with baseline demographic characteristics. We collected solar irradiation dose (SID) and healthcare ranking score (HRS) according to the administrative district from the Korea Meteorological Administration and Korea Health Promotion Institute. The incidence and survival rates were assessed using Pearson's correlation, the Kaplan-Meier estimation, multiple linear regression, and multiple logistic regression methods.
Results
Twenty-five thousand, five hundred ninety-one patients with melanoma were diagnosed during the study period. The age-standardized incidence of melanoma steadily increased from 2004 to 2017 from 2.6 to 3.0/100,000/yr. The incidence of melanoma increased with significantly higher income (p < 0.05). The prevalence followed a similar pattern as the incidence. According to multivariate analysis, HRS significantly influenced the incidence of melanoma in high sun-exposed sites (p < 0.001). There was no significant change in annual mortality. Women had a higher 5-year survival rate than men (78.4% vs. 72.8%). Mortality by the administrative district was highly correlated with HRS.
Conclusion
The incidence of melanoma is increasing in South Korea. A low HRS is associated with both higher incidence and mortality. The findings of this study could be utilized as a guideline for treating melanoma patients.

Citations

Citations to this article as recorded by

Incidence and survival rates of primary cutaneous malignancies in Korea, 1999–2019: A nationwide population‐based study
Soon‐Hyo Kwon, Sangmin Choi, Joung Soo Kim, Sang Seok Kim, Mihn‐Sook Jue, Soo Hong Seo, Jihye Park, Mi Ryung Roh, Je‐Ho Mun, Jun Young Kim, Jee Woong Choi, Ji Won Byun, Sanghyun Park, Min Sung Kim, Seok‐Jong Lee
The Journal of Dermatology.2024; 51(4): 532. CrossRef
The Effect of Interval Training and Urtica Dioica Hydroalcoholic Extract on some Growth and Immune Factors in C57 Rats with Melanoma Cancer
Maryam Firoozi, Alireza Barari, Asieh Abbassi Daloii, Hossein Abednatanzi
Complementary Medicine Journal.2024; 13(4): 44. CrossRef
Hellebrigenin induces apoptosis by triggering cellular inhibitor of apoptosis 1 and Jun N-terminal kinase pathway in melanoma cells
Mu-Kuei Shieu, Yi-Ching Chuang, Hsin-Yu Ho, Chia-Chieh Lin, Yu-Sheng Lo, Ming-Ju Hsieh
Dermatologica Sinica.2024; 42(1): 19. CrossRef
Analyses of Osteogenesis Imperfecta in South Korea Using the Nationwide Health Insurance Service Claim Data: A Propensity Score-Matched Study
Sin Hyung Park, Ho Yoon, Siyeong Yoon, Jaiwoo Chung, Jae-hyun Kim, Soonchul Lee
Calcified Tissue International.2024;[Epub] CrossRef
Pediatric melanoma incidence and survival: a fifteen-year nationwide retrospective cohort study in Korea
Isaac Kim, Jisu Oh, Siyeoung Yoon, Man-Yong Han, Jaiwoo Chung, Younghoon Jung, Hyun-Il Lee, Soonchul Lee
Melanoma Research.2024; 34(6): 528. CrossRef
FOXN3 Regulates Autophagic Activity to Suppress Drug Resistance in Melanoma Cells
Yaqi Wang, Hui Su, Xiaopeng Wang, Chen Tu, Tong Xiao, Bincheng Ren, Shuang Wang
Clinical, Cosmetic and Investigational Dermatology.2024; Volume 17: 2505. CrossRef
The effects of exposure to solar radiation on human health
R. E. Neale, R. M. Lucas, S. N. Byrne, L. Hollestein, L. E. Rhodes, S. Yazar, A. R. Young, M. Berwick, R. A. Ireland, C. M. Olsen
Photochemical & Photobiological Sciences.2023; 22(5): 1011. CrossRef
Survival rates for invasive cutaneous malignant melanoma in South Korea in accordance with the Eighth edition AJCC Cancer Staging Manual: A retrospective single center study
Seon Hwa Lee, Gi Ung Ha, Hyun Ji Lee, Ho Yun Chung, Seung Huh, Dae-Lyong Ha, Kyung Duck Park, Yong Hyun Jang, Weon Ju Lee, Seok-Jong Lee, Jun Young Kim
Indian Journal of Dermatology, Venereology and Leprology.2023; 90: 163. CrossRef
Clinicopathological characteristics and prognosis of Merkel cell carcinoma: a single-center retrospective study in Korea
Ik Jun Moon, Hyungmin Na, Hye Soo Cho, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Woo Jin Lee
Journal of Cancer Research and Clinical Oncology.2023; 149(12): 10065. CrossRef

9,343 View
207 Download
8 Web of Science
9 Crossref

Gastrointestinal cancer

Population Attributable Fraction of Established Modifiable Risk Factors on Colorectal Cancer in Korea: Sooyoung Cho, Aesun Shin; Cancer Res Treat. 2021;53(2):480-486. Published online October 6, 2020; DOI: https://doi.org/10.4143/crt.2019.742

Abstract PDF Supplementary Material PubReader ePub

Purpose
We estimated the population attributable fraction (PAF) of established risk factors for colorectal cancer, to provide evidence for prioritizing cancer prevention policy.
Materials and Methods
The exposure prevalence was calculated by using data from the 2005 Korean National Health Examination Survey for tobacco smoking, alcohol consumption, obesity, physical inactivity, and meat intake. Risk estimates (relative risks) were selected from the published meta-analyses. Cancer incidence data from the Korea Central Cancer Registry were used to estimate the preventable number of colorectal cancer cases in 2015.
Results
The PAFs of the tobacco smoking, alcohol consumption, obesity, physical inactivity, and consumption of red and processed meat were as follows: 9.2%, 11.1%, 9.1%, 18.9%, and 10.1% for colon cancer and 21.8%, 12.3%, 3.5%, 5.3%, and 9.2% for rectal cancer among men; 1.0%, 1.3%, 2.7%, 12.3% and 9.2% for colon cancer and 1.7%, 2.3%, 0.8%, 7.2%, and 8.3% for rectal cancer among women. The PAFs of selected risk factors were 46.2% for colon and 42.4% for rectum among men, while 24.3% for colon and 18.9% for rectum among women. The attributable numbers of colon and rectal cancer to selected risk factors were 4,028 and 3,049 cases among men, respectively, while 1,644 and 778 cases among women in the year of 2015.
Conclusion
Changes in modifiable risk factors could prevent half of the colorectal cancer in the Korean population.

Citations

Citations to this article as recorded by

Population attributable fractions of modifiable cancer risk factors in Korea: A systematic review
Mi Ah Han, Seo‐Hee Kim, Eu Chang Hwang, Jae Hung Jung, Sun Mi Park
Asia-Pacific Journal of Clinical Oncology.2024; 20(2): 299. CrossRef
NME1 and DCC variants are associated with susceptibility and tumor characteristics in Mexican patients with colorectal cancer
Rosa María Márquez-González, Anilú Margarita Saucedo-Sariñana, César de Jesús Tovar-Jacome, Patricio Barros-Núñez, Martha Patricia Gallegos-Arreola, Mario Humberto Orozco-Gutiérrez, Ignacio Mariscal-Ramírez, Tomas Daniel Pineda-Razo, Aldo Antonio Alcaraz-
Journal of the Egyptian National Cancer Institute.2024;[Epub] CrossRef
Relationship Between Aspirin Use and Site-Specific Colorectal Cancer Risk Among Individuals With Metabolic Comorbidity
Seokyung An, Madhawa Gunathilake, Jeonghee Lee, Minji Kim, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
Journal of Korean Medical Science.2024;[Epub] CrossRef
A historical cohort study with 27,754 individuals on the association between meat consumption and gastrointestinal tract and colorectal cancer incidence
Rachel Dankner, Angela Chetrit, Sivan Ben Avraham, Nirit Agay, Ofra Kalter‐Leibovici, Uri Goldbourt, Walid Saliba, Lital Keinan‐Boker, Danit Shahar, Laurence S. Freedman
International Journal of Cancer.2024; 155(11): 2009. CrossRef
Body Mass Index and Risk of Colorectal Cancer Incidence and Mortality in Asia
Pedram Paragomi, Zhongjie Zhang, Sarah Krull Abe, Md. Rashedul Islam, Md. Shafiur Rahman, Eiko Saito, Xiao-Ou Shu, Bashir Dabo, Yen Thi-Hai Pham, Yu Chen, Yu-Tang Gao, Woon-Puay Koh, Norie Sawada, Reza Malekzadeh, Ritsu Sakata, Atsushi Hozawa, Jeongseon K
JAMA Network Open.2024; 7(8): e2429494. CrossRef
Cancers attributable to diet in Italy
Federica Turati, Gianfranco Alicandro, Giulia Collatuzzo, Claudio Pelucchi, Matteo Malvezzi, Fabio Parazzini, Eva Negri, Paolo Boffetta, Carlo La Vecchia, Matteo Di Maso
International Journal of Cancer.2024;[Epub] CrossRef
Influence of Lifestyles on Polyp Burden and Cancer Development in Hereditary Colorectal Cancer Syndromes
Hye Kyung Hyun, Ji Soo Park, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
Journal of Gastroenterology and Hepatology.2024;[Epub] CrossRef
Risk and survival in colorectal cancer with increasing body mass index: A nationwide population‐based cohort study
Usman Saeed, Tor Å. Myklebust, Trude E. Robsahm, Marlene F. Kielland, Bjørn Møller, Bjørn S. Skålhegg, Tom Mala, Sheraz Yaqub
Colorectal Disease.2023; 25(3): 375. CrossRef
Risk factor analysis of malignant adenomas detected during colonoscopy
Hong Hu, Xiaoyuan Gong, Kai Xu, Shenzheng Luo, Wei Gao, Baiwen Li, Dadao Jing
Frontiers in Medicine.2023;[Epub] CrossRef
Associations between Physical Activity and Incidence of Cancer among Overweight Adults in Korea: Results from the Health Examinees-G Study
Jaesung Choi, JooYong Park, Ji-Eun Kim, Miyoung Lee, Daehee Kang, Aesun Shin, Ji-Yeob Choi
Cancer Prevention Research.2023; 16(7): 405. CrossRef
The underestimated impact of excess body weight on colorectal cancer risk: Evidence from the UK Biobank cohort
Fatemeh Safizadeh, Marko Mandic, Dianne Pulte, Tobias Niedermaier, Michael Hoffmeister, Hermann Brenner
British Journal of Cancer.2023; 129(5): 829. CrossRef
Modifiable lifestyle factors have a larger contribution to colorectal neoplasms than family history
Shuyuan Wang, Zhen Yuan, Yuqi Wang, Xuanzhu Zhao, Weifeng Gao, Hongzhou Li, Yuanshun Zhao, Zili Zhang, Shuiqing Liang, Zhaoce Liu, Qinghuai Zhang, Hong Ma, Xipeng Zhang, Wei Cui, Chunze Zhang
BMC Cancer.2022;[Epub] CrossRef

6,968 View
204 Download
12 Crossref

Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database: Jae Seung Lee, In Rae Cho, Hye Won Lee, Mi Young Jeon, Tae Seop Lim, Oidov Baatarkhuu, Do Young Kim, Kwang-Hyub Han, Jun Yong Park; Cancer Res Treat. 2019;51(4):1347-1356. Published online February 12, 2019; DOI: https://doi.org/10.4143/crt.2018.477

Abstract PDF Supplementary Material PubReader ePub

Purpose
Conditional survival estimates (CSE) can provide additional useful prognostic information on the period of survival after diagnosis, which helps in counseling patients with cancer on their individual prognoses. This study aimed to analyze conditional survival (CS) for hepatocellular carcinoma (HCC) using a Korean national registry.
Materials and Methods
Patients with HCC, registered in the Korean cancer registry database, were retrospectively reviewed. Overall survival (OS) was calculated using the Kaplan-Meier method. The 1-year CS at X year or month after diagnosis were calculated as CS1=OS_(X+1)/OS_(X). CS calculations were performed in each Barcelona Clinic Liver Cancer stage, after which patients at stage 0, A, and B underwent subgroup analysis using initial treatment methods.
Results
A total of 4,063 patients diagnosed with HCC from January 2008 to December 2010, and 2,721 who were diagnosed from January 2011 to December 2012, were separately reviewed. In 2008-2010, the 1-year CS of 1, 2, 3, 4, and 5-year survivors was 82.9%, 85.1%, 88.3%, 88.0%, and 88.6%, respectively. Patients demonstrated an increase in CSE over time in subgroup analysis, especially in the advanced stages. In 2011-2012, the 1-year CS of 6, 12, 18, 24, 30, and 36 months was 81.5%, 83.8%, 85.3%, 85.5%, 86.5%, and 88.8%, respectively. The subgroup analysis showed the same tendency towards increased CSE in the advanced stages.
Conclusion
Overall, the CS improved with each additional year after diagnosis in both groups. CSE may therefore provide a more accurate prognosis and hopeful message to patients who are surviving with or after treatment.

Citations

Citations to this article as recorded by

Improving Hepatocellular Carcinoma Surveillance Outcomes in Patients with Cirrhosis after Hepatitis C Cure: A Modelling Study
Jacob Cumming, Nick Scott, Jessica Howell, Joan Ericka Flores, Damian Pavlyshyn, Margaret E. Hellard, Leon Shin-han Winata, Marno Ryan, Tom Sutherland, Alexander J. Thompson, Joseph S. Doyle, Rachel Sacks-Davis
Cancers.2024; 16(15): 2745. CrossRef
Analysis of conditional survival in primary hepatocellular carcinoma after narrow-margin hepatectomy: a large-sample, dual-centre, retrospective study
Jie Kong, Tingfeng Huang, Jianxi Zhang, Shichuan Tang, Hongzhi Liu, Jingfeng Liu, Yongyi Zeng
HPB.2023; 25(2): 179. CrossRef
Factors associated with the survival outcomes of patients with untreated hepatocellular carcinoma: An analysis of nationwide data
Min Jung Kwon, Soy Chang, Ji Hoon Kim, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Pil Soo Sung
Frontiers in Oncology.2023;[Epub] CrossRef
Early diagnosis and prognosis of hepatocellular carcinoma based on a ceRNA array
Li-xin Wang, Ao-ran Kong, Hui Dong
Oncologie.2023; 25(3): 245. CrossRef
Conditional survival probability of distant-metastatic hepatocellular carcinoma: A population-based study
Yong-Ping Yang, Cheng-Jun Guo, Zhao-Xuan Gu, Jun-Jie Hua, Jia-Xuan Zhang, Jian Shi
World Journal of Gastrointestinal Oncology.2023; 15(11): 1874. CrossRef
Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
Hye Won Lee, Kyung Joo Cho, Jun Yong Park
Immune Network.2020;[Epub] CrossRef
Dynamic evaluation of conditional survival in patients with oral squamous cell carcinoma after surgical resection: A large-scale prospective study
Lingjun Yan, Fa Chen, Lin Chen, Jing Lin, Qing Chen, Xiaodan Bao, Yu Qiu, Lisong Lin, Xiaoyan Zheng, Lizhen Pan, Jing Wang, Zhijian Hu, Fengqiong Liu, Baochang He, Bin Shi
Oral Oncology.2020; 104: 104639. CrossRef
Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
Jaewoong Kim, Jin Won Chang, Jun Yong Park
Journal of Liver Cancer.2020; 20(1): 72. CrossRef
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Young Eun Chon, Hana Park, Hye Kyung Hyun, Yeonjung Ha, Mi Na Kim, Beom Kyung Kim, Joo Ho Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Seong Gyu Hwang, Kwang-Hyub Han, Kyu Sung Rim, Jun Yong Park
Cancers.2019; 11(4): 509. CrossRef

7,365 View
140 Download
8 Web of Science
9 Crossref

What We Talk about When We Talk about Caregiving: The Distribution of Roles in Cancer Patient Caregiving in a Family-Oriented Culture: Ansuk Jeong, Dongwook Shin, Jong Hyock Park, Keeho Park; Cancer Res Treat. 2019;51(1):141-149. Published online March 21, 2018; DOI: https://doi.org/10.4143/crt.2017.557

Abstract PDF Supplementary Material PubReader ePub

Purpose
When it comes to cancer care, the psychological well-being of family caregivers has gotten its deserved attention. However, the specific roles that the family caregivers take have not been examined as much. The current study aimed to investigate the distribution of family caregivers’ roles, particularly in a family-oriented culture, Korea.
Materials and Methods
A sample of 439 participants was recruited from 11 national and regional cancer centers in Korea. The participants who were 60 years old or above went through treatments for their gastric, colorectal, or lung cancer. The individual survey included questions regarding the family type, living arrangement, and the sources of support when it comes to their physical, emotional, financial, and decision-making needs.
Results
The responses from the participants showed that cancer caregiving is shared by multiple family caregivers; the major source of support for elderly cancer patients on diverse domains was their spouse; patients’ reliance on their daughter(s) increased for emotional support; and patients’ reliance on their son(s) stood out for financial support and decision-making support. Also, the older the patients were, the heavier their reliance was on the adult children, including sons, daughters, and daughters-in-law.
Conclusion
Future support programs for elderly cancer patients are suggested to involve multiple family caregivers to encourage effective and efficient intervention. Also, the limitations of the current study and the suggestions for future research are discussed.

Citations

Citations to this article as recorded by

Exploring the Lived Experiences of Caregiving for Older Family Members by Young Caregivers in Singapore: Transition, Trials, and Tribulations
Araviinthansai Subramaniam, Kalyani Kirtikar Mehta
International Journal of Environmental Research and Public Health.2024; 21(2): 182. CrossRef
Good Together Makes it Better?
Carolina Blom, Ana Catarina Reis, Leonor Lencastre
European Journal of Psychology Open.2024; 83(3): 119. CrossRef
Caregiving Strain, family functioning, and effort to change diet for patients with gastrointestinal cancer: A cross-sectional descriptive study
Myung Kyung Lee
European Journal of Oncology Nursing.2023; 62: 102264. CrossRef
Preferred and actual involvement of caregivers in oncologic treatment decision-making: A systematic review
Laura M.L. Tielemans, Kirsten D. van Heugten, Marije E. Hamaker, Inez C. van Walree
Journal of Geriatric Oncology.2023; 14(6): 101525. CrossRef
Effectiveness of Nursing Interventions for Patients With Cancer and their Family Members: A Systematic Review
Cristina Alfaro-Díaz, Erla Kolbrun Svavarsdottir, Nuria Esandi, Marianne E. Klinke, Ana Canga-Armayor
Journal of Family Nursing.2022; 28(2): 95. CrossRef
Active Engagement, Protective Buffering, and Depressive Symptoms in Young-Midlife Couples Surviving Cancer: The Roles of Age and Sex
Karen S. Lyons, Jessica R. Gorman, Brandon S. Larkin, Grace Duncan, Brandon Hayes-Lattin
Frontiers in Psychology.2022;[Epub] CrossRef
Exploring positive experiences of primary and secondary caregivers of older persons in resource-limited urban settings in Accra, Ghana
Frank Kyei-Arthur, Samuel Nii Ardey Codjoe, Delali Margaret Badasu, Vijayaprasad Gopichandran
PLOS ONE.2022; 17(4): e0266269. CrossRef
Health practices in Europe towards families of older patients with cancer: a scoping review
Hanne Konradsen, Anne Brødsgaard, Birte Østergaard, Erla Svavarsdóttir, Karin B. Dieperink, Lorenz Imhof, Marie Louise Luttik, Romy Mahrer‐Imhof, Cristina García‐Vivar
Scandinavian Journal of Caring Sciences.2021; 35(2): 375. CrossRef
Family Caregivers' Emotional Preparedness for Death is Distinct from Their Cognitive Prognostic Awareness for Cancer Patients
Siew Tzuh, Wen-Cheng Chang, Wen-Chi Chou, Chia-Hsun Hsieh, Jen-Shi Chen, Fur-Hsing Wen
Journal of Palliative Medicine.2021; 24(3): 405. CrossRef
Exploring perceptions and practices of cancer care among caregivers and care recipients of breast cancer in India
Shradha S. Parsekar, Ajay Bailey, Binu V. S., Suma Nair
Psycho-Oncology.2020; 29(4): 737. CrossRef

8,379 View
183 Download
11 Web of Science
10 Crossref

Projection of Breast Cancer Burden due to Reproductive/Lifestyle Changes in Korean Women (2013-2030) Using an Age-Period-Cohort Model: Joo Eun Lee, Sang Ah Lee, Tae Hyun Kim, Sohee Park, Yoon Soo Choy, Yeong Jun Ju, Eun-Cheol Park; Cancer Res Treat. 2018;50(4):1388-1395. Published online January 22, 2018; DOI: https://doi.org/10.4143/crt.2017.162

Abstract PDF Supplementary Material PubReader ePub

Purpose
The aim of this study was to estimate the burden of breast cancer that can be attributed to rapid lifestyle changes in South Korea in 2013-2030.
Materials and Methods
An age-period-cohort model was used to estimate the incidence and mortality. The Global Burden of Disease Study Group methodwas used to calculate the years of life lost and years lived with disability in breast cancer patients using a nationwide cancer registry. The population attributable riskswere calculated using meta-analyzed relative risk ratios and by assessing the prevalence of risk factors.
Results
Women’s reproductive/lifestyle changes, including advanced maternal age at first childbirth (from 37 to 85 disability-adjusted life years [DALYs] per 100,000 person-years), total period of breastfeeding (from 22 to 46 DALYs per 100,000 person-years), obesity (from 37 to 61 DALYs per 100,000 person-years), alcohol consumption (from 19 to 39 DALYs per 100,000 person-years), oral contraceptive use (from 18 to 27 DALYs per 100,000 person-years), and hormone replacement therapy use (from 2 to 3 DALYs per 100,000 person-years) were identified as factors likely to increase the burden of breast cancer from 2013 to 2030. Approximately, 34.2% to 44.3% of the burden of breast cancer could be avoidable in 2030 with reduction in reproductive/lifestyle risk factors.
Conclusion
The rapid changes of age structure and lifestyle in South Korea during the last decade are expected to strongly increase the breast cancer burden over time unless the risk factors can be effectively modified.

Citations

Citations to this article as recorded by

Triggering Breast Cancer Apoptosis via Cyclin-Dependent Kinase Inhibition and DNA Damage by Novel Pyrimidinone and 1,2,4-Triazolo[4,3-a]pyrimidinone Derivatives
Mohamed N. Abd Al Moaty, Yeldez El Kilany, Laila F. Awad, Saied M. Soliman, Assem Barakat, Nihal A. Ibrahim, Marwa M. Abu-Serie, Matti Haukka, Amira El-Yazbi, Mohamed Teleb
ACS Omega.2024; 9(19): 21042. CrossRef
Survival of female patients with breast cancer in the reproductive age group: A retrospective study using SEER database
Subhadra Priyadarshini, Kunja Bihari Panda
Cancer Research, Statistics, and Treatment.2024; 7(3): 290. CrossRef
Synthesized Age-Period-Cohort Prediction Method: Application to Lung Cancer Mortality in Taiwan
Shih-Yung Su
American Journal of Epidemiology.2023; 192(10): 1712. CrossRef
Folic acid-poly(N-isopropylacrylamide-maltodextrin) nanohydrogels as novel thermo-/pH-responsive polymer for resveratrol breast cancer targeted therapy
Osama R.M. Metawea, Mohamed Teleb, Nesreen S. Haiba, Ahmed O. Elzoghby, Asmaa F. Khafaga, Ahmed E. Noreldin, Sherine N. Khattab, Hosam H. Khalil
European Polymer Journal.2023; 182: 111721. CrossRef
Development of a Breast Cancer Risk Prediction Model Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Korean Women
Jihye Choi, Tae-Woong Ha, Hye-Mi Choi, Han-Byoel Lee, Hee-Chul Shin, Woosung Chung, Wonshik Han
Cancer Epidemiology, Biomarkers & Prevention.2023; 32(9): 1182. CrossRef
Forecast of peak attainment and imminent decline after 2017 of oral cancer incidence in men in Taiwan
Jing-Rong Jhuang, Shih-Yung Su, Chun-Ju Chiang, Ya-Wen Yang, Li-Ju Lin, Tsui-Hsia Hsu, Wen-Chung Lee
Scientific Reports.2022;[Epub] CrossRef
Forecast of a future leveling of the incidence trends of female breast cancer in Taiwan: an age-period-cohort analysis
Yi-Chu Chen, Shih-Yung Su, Jing-Rong Jhuang, Chun-Ju Chiang, Ya-Wen Yang, Chao-Chun Wu, Li-Ju Lin, Wen-Chung Lee
Scientific Reports.2022;[Epub] CrossRef
Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea
Na Liu, Da-Wei Yang, Yan-Xia Wu, Wen-Qiong Xue, Dan-Hua Li, Jiang-Bo Zhang, Yong-Qiao He, Wei-Hua Jia
BMC Cancer.2022;[Epub] CrossRef
An ecological study of obesity-related cancer incidence trends in Australia from 1983 to 2017
Eleonora Feletto, Ankur Kohar, David Mizrahi, Paul Grogan, Julia Steinberg, Clare Hughes, Wendy L. Watson, Karen Canfell, Xue Qin Yu
The Lancet Regional Health - Western Pacific.2022; 29: 100575. CrossRef
Heterogeneous trends of premature mortalities in Japan: joinpoint regression analysis of years of life lost from 2011 to 2019
Satoshi Tsuboi, Tomosa Mine, Tetsuhito Fukushima
Dialogues in Health.2022; 1: 100071. CrossRef
Impact of modifiable reproductive factors on cancer incidence and mortality in Korea: a systematic review protocol
Seo-Hee Kim, Mi Ah Han
BMJ Open.2022; 12(11): e067826. CrossRef
Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study
In Young Choi, Sohyun Chun, Dong Wook Shin, Kyungdo Han, Keun Hye Jeon, Jonghan Yu, Byung Joo Chae, Mina Suh, Yong-Moon Park
Cancers.2021; 13(5): 1177. CrossRef
A novel ‘smart’ PNIPAM-based copolymer for breast cancer targeted therapy: Synthesis, and characterization of dual pH/temperature-responsive lactoferrin-targeted PNIPAM-co-AA
Osama R.M. Metawea, Mona A. Abdelmoneem, Nesreen Saied Haiba, Hosam H. Khalil, Mohamed Teleb, Ahmed O. Elzoghby, Asmaa F. Khafaga, Ahmed E. Noreldin, Fernando Albericio, Sherine N. Khattab
Colloids and Surfaces B: Biointerfaces.2021; 202: 111694. CrossRef
Artificial intelligence in breast ultrasonography
Jaeil Kim, Hye Jung Kim, Chanho Kim, Won Hwa Kim
Ultrasonography.2021; 40(2): 183. CrossRef
Projections of the future burden of cancer in Australia using Bayesian age-period-cohort models
Jessica Katherine Cameron, Peter Baade
Cancer Epidemiology.2021; 72: 101935. CrossRef
Evaluation of the Value of Multiplex MicroRNA Analysis as a Breast Cancer Screening in Korean Women under 50 Years of Age with a High Proportion of Dense Breasts
Ji Young Jang, Eun Young Ko, Ji Soo Jung, Kyung Nam Kang, Yeon Soo Kim, Chul Woo Kim
Journal of Cancer Prevention.2021; 26(4): 258. CrossRef
Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening
Do Yeun Kim, Hannah Lui Park
Journal of Breast Cancer.2020; 23(4): 331. CrossRef
Theory of Planned Behaviour and Health Belief Model: females’ intention on breast cancer screening
Jing Huey Chin, Shaheen Mansori, Angelo Brandelli Costa
Cogent Psychology.2019;[Epub] CrossRef
Effect of age at first use of oral contraceptives on breast cancer risk
Li-Wei Ji, Chun-Xia Jing, Su-Lian Zhuang, Wei-Cheng Pan, Xing-Po Hu
Medicine.2019; 98(36): e15719. CrossRef

9,932 View
266 Download
17 Web of Science
19 Crossref

Nationwide Statistical Analysis of Lymphoid Malignancies in Korea: Hyewon Lee, Hyeon Jin Park, Eun-Hye Park, Hee Young Ju, Chang-Mo Oh, Hyun-Joo Kong, Kyu-Won Jung, Byung-Kiu Park, Eunyoung Lee, Hyeon-Seok Eom, Young-Joo Won; Cancer Res Treat. 2018;50(1):222-238. Published online March 30, 2017; DOI: https://doi.org/10.4143/crt.2017.093

Abstract PDF Supplementary Material PubReader ePub

Purpose
Regional differences in the incidence of lymphoid malignancies have been reported worldwide, but there has been no large-scale epidemiologic analysis in Korea. The aim of this study was to provide a nationwide population-based statistical analysis of Korean patients with lymphoid malignancies.
Materials and Methods
The Korea Central Cancer Registry analyzed the incidence and survival of patients with lymphoid malignancies from the Korean National Cancer Incidence Database. Diseases were grouped by clinically relevant categories based on the 2008 World Health Organization classification.
Results
Overall 65,948 lymphoid diseases were identified between 1999 and 2012. The incidence of most subtypes increased with age, except for precursor cell neoplasms. Male predominance (male:female ratio=1.28:1) was observed. In 2012, annual age-standardized incidence rates per 100,000 persons of Hodgkin’s lymphoma, mature B-cell neoplasm, mature T/natural killer (NK)–cell neoplasm, and precursor cell neoplasm were 0.46, 6.60, 0.95, and 1.50, respectively, and they increased yearly from 1999. Composite Hodgkin’s and non-Hodgkin’s lymphomas were extremely rare. Survival improvement estimated using 5-year relative survival rate was observed in patients with Hodgkin’s lymphoma (71.1%- 83.0%), diffuse large B-cell lymphoma (49.5%-61.5%), plasma cell neoplasms (20.2%- 36.9%), and lymphoblastic lymphoma/leukemia (41.5%-56.3%) between 1993 and 2012. However, survival rates of T/NK-cell lymphoma (excluding cutaneous T-cell lymphoma) ranged from 40.5%-43.5% during the study period. Survival rates decreased with age in most subtypes.
Conclusion
This report presented the subtype-specific statistical analysis of lymphoid malignancies in the Korean population, showing increasing incidences and survival rates in most subtypes.

Citations

Citations to this article as recorded by

Incidence and survival rates of primary cutaneous malignancies in Korea, 1999–2019: A nationwide population‐based study
Soon‐Hyo Kwon, Sangmin Choi, Joung Soo Kim, Sang Seok Kim, Mihn‐Sook Jue, Soo Hong Seo, Jihye Park, Mi Ryung Roh, Je‐Ho Mun, Jun Young Kim, Jee Woong Choi, Ji Won Byun, Sanghyun Park, Min Sung Kim, Seok‐Jong Lee
The Journal of Dermatology.2024; 51(4): 532. CrossRef
Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Jinhang Kim, Chang-Hoon Lee, Ga-Young Song, Deok-Hwan Yang, Jae-Yong
The Korean Journal of Internal Medicine.2024; 39(3): 501. CrossRef
The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype
Yu Aruga, Chiaki Ikeda, Hiromichi Matsushita, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Koji Izutsu, Hirotaka Matsui
Scientific Reports.2024;[Epub] CrossRef
Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study
Boyoung Park, Eunyoung Lee, Junghyun Yoon, YoungJu Park, Hyeon-Seok Eom
Cancer Research and Treatment.2024; 56(3): 936. CrossRef
Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
Moonho Kim, Yongchel Ahn, Heui-June Ahn, Suk-Hun Ha, Ho-Suk Oh, Jae-Seok Song, Woong-Sub Park, Sang-Wook Yi
Annals of Hematology.2023; 102(11): 3167. CrossRef
Incidence Trend of Follicular Lymphoma in Taiwan Compared to Japan and Korea, 2001–2019
Liang-Chun Chiu, Chih-Wen Lin, Hung-Ju Li, Jian-Han Chen, Fu-Cheng Chuang, Sheng-Fung Lin, Yu Chang, Yu-Chieh Su
Journal of Clinical Medicine.2023; 12(4): 1417. CrossRef
Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
Youngwoo Jeon, Duk-Hwan Yang, Suk-Joong Oh, Jin-Hee Park, Jung-Ah Kim, Sung-Young Kim, Chul-Won Choi, Won-Sik Lee, In-Ho Kim, Yeung-Chul Mun, Gi June Min, Ki-Seong Eom, Seok-Goo Cho
Frontiers in Oncology.2023;[Epub] CrossRef
Mycosis fungoides and Sézary syndrome
Hyewon Lee
Blood Research.2023; 58(S1): S66. CrossRef
A population-based analysis of hematological malignancies from a French-West-Indies cancer registry’s data (2009–2018)
Rémi Houpert, Thierry Almont, Rostom Belahreche, Mamadi Faro, Jennie Okouango, Mylène Vestris, Jonathan Macni, Olivier Pierre-Louis, Christelle Montabord, Murielle Beaubrun-Renard, Naby Soumah, Martial Boisseau, Jacqueline Véronique-Baudin, Clarisse Joach
BMC Cancer.2023;[Epub] CrossRef
A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
Yong-Pyo Lee, Ye Ji Jung, Junhun Cho, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim, Sang Eun Yoon
Blood Research.2023; 58(4): 208. CrossRef
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
Do Young Kim, Jehyun Nam, Joo-seop Chung, Sang-Woo Kim, Ho-Jin Shin
Cancer Research and Treatment.2022; 54(1): 301. CrossRef
Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data
Yu-Chieh Su, Brian Chih-Hung Chiu, Hung-Ju Li, Wen-Chi Yang, Tsai-Yun Chen, Su-Peng Yeh, Ming-Chung Wang, Wen-Tsung Huang, Ming-Yang Lee, Sheng-Fung Lin, Carla Pegoraro
PLOS ONE.2022; 17(3): e0265543. CrossRef
Stem cell transplant for mantle cell lymphoma in Taiwan
Yu-Hung Wang, Ching-Yun Hsieh, Liang-Tsai Hsiao, Tung-Liang Lin, Yi-Chang Liu, Ming Yao, Tran-Der Tan, Bor-Sheng Ko
Scientific Reports.2022;[Epub] CrossRef
Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments
Preetesh Jain, Michael L. Wang
American Journal of Hematology.2022; 97(5): 638. CrossRef
The Relationships between Physical Activity, Exercise, and Sport on the Immune System
Pedro Forte, Luís Branquinho, Ricardo Ferraz
International Journal of Environmental Research and Public Health.2022; 19(11): 6777. CrossRef
Utility of Epstein-Barr Viral Load in Blood for Diagnosing and Predicting Prognosis of Lymphoma
Junhyup Song, Jun Yong Kim, Sinyoung Kim, Younhee Park
The Journal of Molecular Diagnostics.2022; 24(9): 977. CrossRef
Advances in quantum dot-based biosensors for DNA-modifying enzymes assay
Qian Zhang, Xinyi Zhang, Fei Ma, Chun-yang Zhang
Coordination Chemistry Reviews.2022; 469: 214674. CrossRef
Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
Shuo Liu, Weiping Liu, Huichao Li, Lei Yang, Yuqin Song, Xi Zhang, Yangyang Cheng, Qingyu Li, Haoxin Li, Ning Wang, Jun Zhu, Jiafu Ji
Frontiers in Oncology.2022;[Epub] CrossRef
Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma
Nuchjira Takheaw, Gunya Sittithumcharee, Ryusho Kariya, Watchara Kasinrerk, Seiji Okada
Cancer Immunology, Immunotherapy.2021; 70(6): 1557. CrossRef
Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study
Yunsuk Choi, Jung-Hee Lee, Chul Won Jung, Jae-Cheol Jo, Jin Seok Kim, Inho Kim, Silvia Park, June-won Cheong, Sang-Hyuk Park, Sung-Yong Kim, Hong-Ghi Lee
The Korean Journal of Internal Medicine.2021; 36(1): 194. CrossRef
High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma
Jongheon Jung, Hyewon Lee, Ja Yoon Heo, Myung Hee Chang, Eunyoung Lee, Weon Seo Park, Ju-Hyun Park, Hyeon-Seok Eom
Scientific Reports.2021;[Epub] CrossRef
Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
Jun Ho Yi, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Myung Hee Chang, Deok Hwan Yang, Jae‐Cheol Jo, Shin Young Hyun, Hyeon‐Seok Eom, Jeong‐Ok Lee, Ji Hyun Kwon, Sang Hoon Han, Seung‐Shin Lee, Jae‐Yong Kwak, Se Hyung Kim, Dae Sik Kim, Ji Hyun Lee, Sung Yo
Cancer Communications.2021; 41(3): 275. CrossRef
A Case of Herpes Zoster Granulomatous Dermatitis: Report of Wolf's Isotopic Response
Ji ha Yoon, Ye ji Jang, Eun joo Park, Kwang joong Kim, Kwang ho Kim
Annals of Dermatology.2021; 33(2): 186. CrossRef
An Updated Review of Chronic Lymphocytic Leukemia
Hee Jeong Cho, Sang Kyun Sohn
The Korean Journal of Medicine.2021; 96(3): 195. CrossRef
Towards an Ensemble Vaccine against the Pegivirus Using Computational Modelling Approaches and Its Validation through In Silico Cloning and Immune Simulation
Bowen Zheng, Muhammad Suleman, Zonara Zafar, Syed Shujait Ali, Syed Nouman Nasir, Namra, Zahid Hussain, Muhammad Waseem, Abbas Khan, Fakhrul Hassan, Yanjing Wang, Dongqing Wei
Vaccines.2021; 9(8): 818. CrossRef
Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution
Meejeong Kim, Hee Sang Hwang, Hyungwoo Cho, Dok Hyun Yoon, Cheolwon Suh, Chan Sik Park, Heounjeong Go, Jooryung Huh
Journal of Pathology and Translational Medicine.2021; 55(5): 330. CrossRef
Trends Analysis of Non-Hodgkin Lymphoma at the National, Regional, and Global Level, 1990–2019: Results From the Global Burden of Disease Study 2019
Wenwen Cai, Qingle Zeng, Xingxing Zhang, Weiqing Ruan
Frontiers in Medicine.2021;[Epub] CrossRef
Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea
Jun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, Kwai Han Yoo, Chul Won Jung, Dae Sik Kim, Jeong-Ok Lee, Hyeon Seok Eom, Ja Min Byun, Youngil Koh, Sung Soo Yoon, Jin Seok Kim, Jee Hyun Kong, Ho-Young Yhim, Deok-Hwan Yang, Dok Hyun Yoon, Do Hyoung Lim, Won-Sik Lee,
BLOOD RESEARCH.2021; 56(4): 243. CrossRef
Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018
Won-Ju Park, Joo-heon Park, Seunghyeon Cho, Myung Geun Shin
BLOOD RESEARCH.2021; 56(4): 301. CrossRef
Prediagnostic blood levels of organochlorines and risk of non‐Hodgkin lymphoma in three prospective cohorts in China and Singapore
Bryan A. Bassig, Xiao‐Ou Shu, Andreas Sjödin, Woon‐Puay Koh, Yu‐Tang Gao, Jennifer Adams‐Haduch, Mark Davis, Renwei Wang, Yong‐Bing Xiang, Lawrence S. Engel, Mark P. Purdue, Bu‐Tian Ji, Gong Yang, Richard S. Jones, Hilde Langseth, H. Dean Hosgood, Tom K.
International Journal of Cancer.2020; 146(3): 839. CrossRef
Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients
Young Ae Kim, Hee Young Ju, Hyeon Jin Park, Na Young Lee, Hyun Jeong Lee, Hyewon Lee, Haryeom Ghang
British Journal of Haematology.2020; 188(5): 740. CrossRef
Value of multi-parameter flow cytometry immunophenotyping in T/NK-cell neoplasms in cytology specimens: A retrospective study in Chinese patients
Yuwei Zheng, Xiaochun Wan, Xian Gui, Ying Chen, Lili Gao, Hao Zhang, Yanli Wang
Pathology - Research and Practice.2020; 216(8): 152921. CrossRef
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
Dok Hyun Yoon, Junning Cao, Tsai-Yun Chen, Koji Izutsu, Seok Jin Kim, Yok Lam Kwong, Tong Yu Lin, Lim Soon Thye, Bing Xu, Deok Hwan Yang, Won Seog Kim
Journal of Hematology & Oncology.2020;[Epub] CrossRef
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma
Kyoung Ha Kim, Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Hye Jin Kang, Chul Won Choi, Ho Sup Lee, Sung Hwa Bae, Jinny Park, Eun Kyung Park, Jae‐Yong Kwak, Mark Hong Lee, Byung Woog Kang, Sung‐Kyu Park, Jong‐Ho Won
Transplant International.2020; 33(10): 1211. CrossRef
Recent advances in chronic lymphocytic leukemia therapy
Jieun Uhm
BLOOD RESEARCH.2020; 55(S1): S72. CrossRef
Trends of Incidence and Survival Rrates of Mucosa-associated Lymphoid Tissue Lymphoma in the Korean Population: Analysis of the Korea Central Cancer Registry Database
Seok-Hoo Jeong, Shin Young Hyun, Ja Sung Choi, Hee Man Kim
Journal of Korean Medical Science.2020;[Epub] CrossRef
Lifestyle and risk of follicular lymphoma: a systematic review and meta-analysis of observational studies
Michael K. Odutola, Eriobu Nnakelu, Graham G. Giles, Marina T. van Leeuwen, Claire M. Vajdic
Cancer Causes & Control.2020; 31(11): 979. CrossRef
Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
Hye Park, Eun Han, Joo O, Byung-Ock Choi, Gyeongsin Park, Seung-Eun Jung, Seung-Ah Yahng, Ki-Seong Eom, Seok-Goo Cho
Diagnostics.2020; 10(12): 1002. CrossRef
Mortality of lymphoma and myeloma in China, 2004–2017: an observational study
Weiping Liu, Jiangmei Liu, Yuqin Song, Xiaopei Wang, Maigeng Zhou, Lijun Wang, Jun Ma, Jun Zhu
Journal of Hematology & Oncology.2019;[Epub] CrossRef
Vitamin D status and risk of non-Hodgkin lymphoma: An updated meta-analysis
Hye Yin Park, Yun-Chul Hong, Kyoungho Lee, Jaewoo Koh, Matteo Rota
PLOS ONE.2019; 14(4): e0216284. CrossRef
Advances in the Treatment of Childhood Acute Lymphoblastic Leukemia
Hyery Kim
Clinical Pediatric Hematology-Oncology.2019; 26(1): 12. CrossRef
Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997–2016
Jongmin Sim, Takuya Takayama, Junhun Cho, Seok Jin Kim, Won Seog Kim, Howe J. Ree, Young Hyeh Ko
Medicine.2019; 98(45): e17641. CrossRef
Classification of malignant lymphoma subtypes in Korean patients: a report of the 4th nationwide study
Hye-Ra Jung, Jooryung Huh, Young-Hyeh Ko, Yoon Kyung Jeon, Sun Och Yoon, Se Hoon Kim, Woo Ick Yang, Geongsin Park, Jo Heon Kim, Jin Ho Paik, Jae Ho Han, Hee Jung Cha, Kyu Yun Jang, Bong-Kyung Shin, Young-A Kim, Ji Eun Kim, Yoo Duk Choi, Min Gyoung Park, H
Journal of Hematopathology.2019; 12(4): 173. CrossRef
Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
Weiping Liu, Jiangmei Liu, Yuqin Song, Xinying Zeng, Xiaopei Wang, Lan Mi, Cai Cai, Lijun Wang, Jun Ma, Jun Zhu
Journal of Hematology & Oncology.2019;[Epub] CrossRef
Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial
Kwai Han Yoo, Hyewon Lee, Cheolwon Suh
International Journal of Hematology.2018; 107(4): 395. CrossRef
Subtype‐specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002‐2012
Bor‐Sheng Ko, Li‐Ju Chen, Huai‐Hsuan Huang, Yao‐Chun Wen, Chi‐Yin Liao, Ho‐Min Chen, Fei‐Yuan Hsiao
Cancer Medicine.2018; 7(11): 5820. CrossRef
Gastric follicular lymphoma: A report of 3ï¿½cases and a review of the literature
Hee Na, Young Kim, Cheol Lee, Ji‑Young Choe, Seon Shin, Jung‑Weon Shim, Soo Min, Hyun‑Jung Kim, Jae Han, Ji Kim
Oncology Letters.2018;[Epub] CrossRef

17,048 View
645 Download
47 Web of Science
47 Crossref

Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea: Gebra Cuyun Carter, Anna Kaltenboeck, Jasmina Ivanova, Astra M. Liepa, Alexandra San Roman, Maria Koh, Narayan Rajan, Rebecca Cheng, Howard G. Birnbaum, Jong Seok Kim, Yung-Jue Bang; Cancer Res Treat. 2017;49(3):578-587. Published online September 12, 2016; DOI: https://doi.org/10.4143/crt.2016.001

Abstract PDF PubReader ePub

Purpose
The purpose of this study was to understand patient treatment patterns, outcomes, and healthcare resource use in cases of metastatic and/orlocally recurrent, unresectable gastric cancer (MGC) in South Korea.
Materials and Methods
Thirty physicians reviewed charts of eligible patients to collect de-identified data. Patients must have received platinum/fluoropyrimidine first-line therapy followed by second-line therapy or best supportive care, had no other primary cancer, and not participated in a clinical trial following MGC diagnosis. Data were summarized using descriptive statistics. Kaplan-Meier analysis was used to describe survival.
Results
Of 198 patients, 73.7% were male, 78.3% were diagnosed with MGC after age 55 (mean, 61.3 years), and 47.0% were current orformer smokers. The majority of tumorswere located in the antrum/pylorus (51.5%). Metastatic sites most often occurred in the peritoneum (53.5%), lymph nodes (47.5%), and liver (38.9%). At diagnosis, the mean Charlson comorbidity indexwas 0.4 (standard deviation, 0.6). The most common comorbiditieswere chronic gastritis (22.7%) and cardiovascular disease (18.7%). Most patients (80.3%) received second-line treatment. Single-agent fluoropyrimidine was reported for 22.0% of patients, while 19.5% were treated with irinotecan and a fluoropyrimidine or platinum agent. The most common physician-reported symptoms during second-line treatment were nausea/vomiting (44.7%) and pain (11.3%), with antiemetics (44.7%), analgesics (36.5%), and nutritional support (11.3%) most often used as supportive care. Two-thirds of inpatient hospitalizations were for chemotherapy infusion. Outpatient hospitalization (31.6%) and visits to the oncologist (58.8%) were common among second-line patients.
Conclusion
Most patients received second-line treatment, although regimens varied. Understanding MGC patient characteristics and treatment patterns in South Korea will help address unmet needs.

Citations

Citations to this article as recorded by

A Pilot Analysis of Capecitabine Plus PD‐1 Antibody as Maintenance Therapy in Advanced or Metastatic Gastric Cancer and the Prognostic Factors
Dong‐Liang Chen, Yan Hu, Dong‐Sheng Zhang, Feng‐Hua Wang
Advanced Therapeutics.2024;[Epub] CrossRef
A Novel Hematological Inflammation-Nutrition Score (HINS) and Its Related Nomogram Model to Predict Survival Outcome in Advanced Gastric Cancer Patients Receiving First-Line Palliative Chemotherapy
Chen Chen, Zehua Wang, Yanru Qin
Journal of Inflammation Research.2023; Volume 16: 2929. CrossRef
Daily practices in chemotherapy for advanced gastric or gastroesophageal junction adenocarcinoma: METESTOMAC French prospective cohort
Sylvain Manfredi, Marie Dior, Olivier Bouche, Emilie Barbier, Vincent Hautefeuille, Marielle Guillet, Justine Turpin, Vincent Bourgeois, Dall Osto Helene, Romain Desgrippes, Franck Audemar, Yann Molin, Christophe Locher, Thierry Chatellier, Thierry Lecomt
Cancer Medicine.2023; 12(5): 5341. CrossRef
A Randomized Phase III Study of Patients With Advanced Gastric Adenocarcinoma Without Progression After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation
Guk Jin Lee, Hyunho Kim, Sung Shim Cho, Hyung Soon Park, Ho Jung An, In Sook Woo, Jae Ho Byun, Ji Hyung Hong, Yoon Ho Ko, Der Sheng Sun, Hye Sung Won, Jong Youl Jin, Ji Chan Park, In-Ho Kim, Sang Young Roh, Byoung Yong Shim
Journal of Gastric Cancer.2023; 23(2): 315. CrossRef
Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE‐063): A randomized, open‐label, phase 3 trial in Asian patients
Hyun Cheol Chung, Yoon‐Koo Kang, Zhendong Chen, Yuxian Bai, Wan Zamaniah Wan Ishak, Byoung Yong Shim, Young Lee Park, Dong‐Hoe Koo, Jianwei Lu, Jianming Xu, Hong Jae Chon, Li‐Yuan Bai, Shan Zeng, Ying Yuan, Yen‐Yang Chen, Kangsheng Gu, Wen Yan Zhong, Shu
Cancer.2022; 128(5): 995. CrossRef
Clinical Impact of Prognostic Nutrition Index for Advanced Gastric Cancer Patients with Peritoneal Metastases Treated Nivolumab Monotherapy
Jungmin Lee, Soo Ho Choi, Jin Ho Baek, Dong Won Baek, Jong Gwang Kim, Byung Woog Kang
Chonnam Medical Journal.2022; 58(1): 24. CrossRef
A global perspective in second‐line treatment patterns for patients with advanced esophageal squamous cell carcinoma
Dena H. Jaffe, Joseph Gricar, Marc DeCongelio, deMauri S. Mackie
Thoracic Cancer.2022; 13(9): 1240. CrossRef
Current therapeutic options for gastric adenocarcinoma
C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
Saudi Journal of Biological Sciences.2021; 28(9): 5371. CrossRef
A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care
K. Shimozaki, I. Nakayama, D. Takahari, D. Kamiimabeppu, H. Osumi, T. Wakatsuki, A. Ooki, M. Ogura, E. Shinozaki, K. Chin, K. Yamaguchi
ESMO Open.2021; 6(5): 100234. CrossRef
Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)
Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, Min-Hee Ryu, Se Hoon Park, Sun Young Rha, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, In-Ho Kim, Sun Jin Sym, So Yeon Oh, Hyeong Su Kim, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young
Therapeutic Advances in Medical Oncology.2021;[Epub] CrossRef
Clinical management patterns of advanced and metastatic gastro‐oesophageal carcinoma after fluoropyrimidine/platinum treatment in France, Germany, Spain and the United Kingdom
Jacqueline Brown, Astra M. Liepa, Bela Bapat, Shweta Madhwani, Sylvie Lorenzen, Jesús García‐Foncillas, Sean D. Candrilli, James A. Kaye
European Journal of Cancer Care.2020;[Epub] CrossRef
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer
David Gómez-Ulloa, Mayur Amonkar, Smita Kothari, Winson Y. Cheung, Ian Chau, John R. Zalcberg, Núria Lara Suriñach, Alfredo Falcone
BMC Gastroenterology.2020;[Epub] CrossRef
Treatment Patterns Among Patients with Metastatic and/or Unresectable Gastric Cancer in Brazil
Fernando Meton de Alencar Camara Vieira, Ana Paula Ornellas de Souza Victorino, Daniel de Iracema Gomes Cubero, Carlos Augusto de Mendonça Beato, Eimy Minowa, Guilherme Silva Julian, Diego Novick
Journal of Gastrointestinal Cancer.2019; 50(4): 780. CrossRef
Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
Jin Won Kim, Jong Gwang Kim, Byung Woog Kang, Ik-Joo Chung, Young Seon Hong, Tae-You Kim, Hong Suk Song, Kyung Hee Lee, Dae Young Zang, Yoon Ho Ko, Eun-Kee Song, Jin Ho Baek, Dong‐Hoe Koo, So Yeon Oh, Hana Cho, Keun-Wook Lee
Cancer Research and Treatment.2019; 51(1): 223. CrossRef
Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study
Sergei A. Tjulandin, Alexey A. Tryakin, Natalia S. Besova, Evgeniya Sholokhova, Jasmina I. Ivanova, Wendy Y. Cheng, Luke M. Schmerold, Philippe Thompson-Leduc, Diego Novick
Journal of Drug Assessment.2019; 8(1): 150. CrossRef
Clinical efficacy of apatinib in treating metastatic gastric cancer and its effect on IL‑17
Ran Chen, Qi‑Tian Chen, You‑Hong Dong
Oncology Letters.2019;[Epub] CrossRef
Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review
Miguel Quintana, José A. Toriz, Diego Novick, Kyla Jones, Brenda S. Botello, Juan Alejandro Silva
PharmacoEconomics - Open.2018; 2(2): 191. CrossRef
Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients
Michael Davidson, Catherine Cafferkey, Emily Frances Goode, Kyriakos Kouvelakis, Daniel Hughes, Pablo Reguera, Eleftheria Kalaitzaki, Clare Peckitt, Sheela Rao, David Watkins, Ian Chau, David Cunningham, Naureen Starling
Clinical Colorectal Cancer.2018; 17(3): 223. CrossRef

11,747 View
428 Download
18 Web of Science
18 Crossref

Current Trends of Lung Cancer Surgery and Demographic and Social Factors Related to Changes in the Trends of Lung Cancer Surgery: An Analysis of the National Database from 2010 to 2014: Samina Park, In Kyu Park, Eung Re Kim, Yoohwa Hwang, Hyun Joo Lee, Chang Hyun Kang, Young Tae Kim; Cancer Res Treat. 2017;49(2):330-337. Published online July 18, 2016; DOI: https://doi.org/10.4143/crt.2016.196

Abstract PDF PubReader ePub

Purpose
We investigated current trends in lung cancer surgery and identified demographic and social factors related to changes in these trends.
Materials and Methods
We estimated the incidence of lung cancer surgery using a procedure code-based approach provided by the Health Insurance Review and Assessment Service (http://opendata.hira.or.kr). The population data were obtained every year from 2010 to 2014 from the Korean Statistical Information Service (http://kosis.kr/). The annual percent change (APC) and statistical significance were calculated using the Joinpoint software.
Results
From January 2010 to December 2014, 25,687 patients underwent 25,921 lung cancer surgeries, which increased by 45.1% from 2010 to 2014. The crude incidence rate of lung cancer surgery in each year increased significantly (APC, 9.5; p < 0.05). The male-to-female ratio decreased from 2.1 to 1.6 (APC, −6.3; p < 0.05). The incidence increased in the age group of ≥ 70 years for both sexes (male: APC, 3.7; p < 0.05; female: APC, 5.96; p < 0.05). Furthermore, the proportion of female patients aged ≥ 65 years increased (APC, 7.2; p < 0.05), while that of male patients aged < 65 years decreased (APC, −3.9; p < 0.05). The proportions of segmentectomies (APC, 17.8; p < 0.05) and lobectomies (APC, 7.5; p < 0.05) increased, while the proportion of pneumonectomies decreased (APC, −6.3; p < 0.05). Finally, the proportion of patients undergoing surgery in Seoul increased (APC, 1.1; p < 0.05), while the proportion in other areas decreased (APC, −1.5; p < 0.05).
Conclusion
An increase in the use of lung cancer surgery in elderly patients and female patients, and a decrease in the proportion of patients requiring extensive pulmonary resection were identified. Furthermore, centralization of lung cancer surgery was noted.

Citations

Citations to this article as recorded by

Clinical characteristics and course of pulmonary artery stump thrombosis following lung cancer surgery: A retrospective study from tertiary care hospital
Ji-Eun Park, Seung-Ick Cha, Deok Heon Lee, Eung Bae Lee, Sun Ha Choi, Yong Hoon Lee, Hyewon Seo, Seung-Soo Yoo, Shin-Yup Lee, Jaehee Lee, Chang-Ho Kim, Jae-Yong Park
Medicine.2024; 103(2): e36879. CrossRef
Lung cancer screening, diagnosis, and treatment: The radiologist's perspective
Bingqing Long, Zeng Xiong, Manzo Habou
Meta-Radiology.2024; 2(1): 100066. CrossRef
Inter-prefectural and urban–rural regional disparities in lung cancer surgery: a Japanese nationwide population-based cohort study from 2017 to 2019
Masamitsu Kido, Satoru Okada, Naoyuki Takashima, Luying Yan, Atsuki Uchibori, Koji Sensaki, Tetsuo Kido, Masayoshi Inoue
Surgery Today.2024; 54(12): 1428. CrossRef
Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair study
Seyer Safi, Maximilian Robert Gysan, Dorothea Weber, Rouven Behnisch, Thomas Muley, Michael Allgäuer, Hauke Winter, Hans Hoffmann, Martin Eichhorn
World Journal of Surgical Oncology.2024;[Epub] CrossRef
Advanced surgical technologies for lung cancer treatment: Current status and perspectives
Hongfei Cai, Yonghui Wang, Da Qin, Youbin Cui, Hongbo Zhang
Engineered Regeneration.2023; 4(1): 55. CrossRef
Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: a nationwide cohort study
Jae Ho Jeong, Jinhong Jung, Hee Jeong Kim, Jong Won Lee, Beom-Seok Ko, Byung Ho Son, Kyung Hae Jung, Il Yong Chung
Annals of Surgical Treatment and Research.2023; 104(2): 71. CrossRef
Crataegus pinnatifida Bunge root extract induces apoptosis of murine lung carcinoma cells in vitro
Minjeong Kwon, Jongbeom Chae, Ju-Ock Nam
Journal of Applied Biological Chemistry.2023;[Epub] CrossRef
Disparities in lung cancer short- and long-term outcomes after surgery: Analysis from the national cancer database
Mark R. Korst, Aman M. Patel, Daniel J. Garcia, Akash R. Patel, Hassaam S. Choudhry, Joseph G. Santitoro, Vincent Yeung, Joshua A. Kra
Cancer Treatment and Research Communications.2023; 37: 100777. CrossRef
Trend of lung cancer surgery, hospital selection, and survival between 2005 and 2016 in South Korea
Dohun Kim, Gil‐Won Kang, Hoyeon Jang, Jun Yeun Cho, Bumhee Yang, Hee Chul Yang, Jinwook Hwang
Thoracic Cancer.2022; 13(2): 210. CrossRef
Current Status of Lung Cancer and Surgery Based on Studies Using a Nationwide Database
Dohun Kim, Jung-Won Lee
Journal of Chest Surgery.2022; 55(1): 1. CrossRef
Assessment of textbook outcome after lobectomy for early‐stage non‐small cell lung cancer in a Korean institution: A retrospective study
Woo Sik Yu, Jaeyong Shin, Jung A Son, Joonho Jung, Seokjin Haam
Thoracic Cancer.2022; 13(8): 1211. CrossRef
Pulmonary vein stump thrombosis after lung resection for lung cancer: clinical features and outcome
Ji-Eun Park, Seung-Ick Cha, Deok Heon Lee, Eung Bae Lee, Sun Ha Choi, Yong Hoon Lee, Hyewon Seo, Seung-Soo Yoo, Shin-Yup Lee, Jaehee Lee, Chang-Ho Kim, Jae-Yong Park
Blood Coagulation & Fibrinolysis.2022; 33(6): 295. CrossRef
Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study
Sung Hoon Jeong, Hyeon Ji Lee, Choa Yun, Il Yun, Yun Hwa Jung, Soo Young Kim, Hee Seung Lee, Sung-In Jang
BMC Cancer.2022;[Epub] CrossRef
Trends in the traditional cardiothoracic surgery resident operative experience for cardiac cases: An analysis of Accreditation Council for Graduate Medical Education case logs
Aakash M. Shah, Emaad Siddiqui, Sari D. Holmes, Alexis Okoh, Mohamed Abdullah, Kristopher Deatrick, Sunjay Kaushal, Justin Sambol
The Journal of Thoracic and Cardiovascular Surgery.2021; 161(3): 1064. CrossRef
Does Delaying Time in Cancer Treatment Affect Mortality? A Retrospective Cohort Study of Korean Lung and Gastric Cancer Patients
Kyu-Tae Han, Woorim Kim, Seungju Kim
International Journal of Environmental Research and Public Health.2021; 18(7): 3462. CrossRef
Neoadjuvant immunotherapy for non-small cell lung cancer: right drugs, right patient, right time?
Elizabeth Ahern, Ben J Solomon, Rina Hui, Nick Pavlakis, Ken O'Byrne, Brett G M Hughes
Journal for ImmunoTherapy of Cancer.2021; 9(6): e002248. CrossRef
Do Patients Residing in Provincial Areas Transport and Spend More on Cancer Treatment in Korea?
Woorim Kim, Kyu-Tae Han, Seungju Kim
International Journal of Environmental Research and Public Health.2021; 18(17): 9247. CrossRef
Pulmonary Metastasectomy in Colorectal Cancer: A Population-Based Retrospective Cohort Study Using the Korean National Health Insurance Database
Woo Sik Yu, Mi Kyung Bae, Jung Kyu Choi, Young Ki Hong, In Kyu Park
Cancer Research and Treatment.2021; 53(4): 1104. CrossRef
Rare location and drainage pattern of right pulmonary veins and aberrant right upper lobe bronchial branch: A case report
Fu-Qiang Wang, Rui Zhang, Han-Lu Zhang, Yun-Hai Mo, Yu Zheng, Guang-Hao Qiu, Yun Wang
World Journal of Clinical Cases.2021; 9(32): 9954. CrossRef
Comment on: ‘Hospital lung surgery volume and patient outcomes’
Rob Stirling, Michael Stenger, John Zalcberg
Lung Cancer.2020; 142: 138. CrossRef
Outcomes after aortic aneurysm repair in patients with history of cancer: a nationwide dataset analysis
Sanghyun Ahn, Jin-Young Min, Hyunyoung G. Kim, Hyejin Mo, Seung-Kee Min, Sangil Min, Jongwon Ha, Kyoung-Bok Min
BMC Surgery.2020;[Epub] CrossRef
Time trends and predictors of survival in surgically resected early‐stage non–small cell lung cancer patients
Jitesh B. Shewale, Erin M. Corsini, Arlene M. Correa, Eric L. Brown, Luis G. Leon‐Novelo, Alan G. Nyitray, Mara B. Antonoff, Wayne L. Hofstetter, Reza J. Mehran, David C. Rice, Jack Roth, Garrett L. Walsh, Ara A. Vaporciyan, Stephen G. Swisher, Boris Sepe
Journal of Surgical Oncology.2020; 122(3): 495. CrossRef
Patterns of percutaneous transthoracic needle biopsy (PTNB) of the lung and risk of PTNB-related severe pneumothorax: A nationwide population-based study
Bo Ram Yang, Mi-Sook Kim, Chang Min Park, Soon Ho Yoon, Kum Ju Chae, Joongyub Lee, James West
PLOS ONE.2020; 15(7): e0235599. CrossRef
Surgical Treatment of Lung Cancer
Haley Hoy, Thuy Lynch, Monica Beck
Critical Care Nursing Clinics of North America.2019; 31(3): 303. CrossRef
Higher Age Puts Lung Cancer Patients at Risk for Not Receiving Anti-cancer Treatment
Won-Il Choi, Jiah Choi, Mi-Ae Kim, Gyumin Lee, Jihyeon Jeong, Choong Won Lee
Cancer Research and Treatment.2019; 51(3): 1241. CrossRef
Recent Trends in Demographics, Surgery, and Prognosis of Patients with Surgically Resected Lung Cancer in a Single Institution from Korea
Jae Kwang Yun, Han Pil Lee, Geun Dong Lee, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Sehoon Choi
Journal of Korean Medical Science.2019;[Epub] CrossRef
Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)
Elizabeth Ahern, Annette Cubitt, Emma Ballard, Michele W. L. Teng, William C. Dougall, Mark J. Smyth, David Godbolt, Rishendran Naidoo, Amanda Goldrick, Brett G. M. Hughes
Trials.2019;[Epub] CrossRef
Progress in the Management of Early-Stage Non–Small Cell Lung Cancer in 2017
Jessica S. Donington, Young Tae Kim, Betty Tong, Andre L. Moreira, Jamie Bessich, Kathleen D. Weiss, Yolonda L. Colson, Dennis Wigle, Raymond U. Osarogiagbon, Jeffrey Zweig, Heather Wakelee, Justin Blasberg, Megan Daly, Leah Backhus, Paul Van Schil
Journal of Thoracic Oncology.2018; 13(6): 767. CrossRef

10,587 View
290 Download
19 Web of Science
28 Crossref

First
Prev
Page of 1
Next
Last

Search